{"schema_version":"1","generated_at":"2026-11-12T01:09:52.852Z","data_as_of":null,"url":"https://www.findmykol.com/kol/revathi-angitapalli","json_url":"https://www.findmykol.com/kol/revathi-angitapalli/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"revathi-angitapalli","name":"Revathi Angitapalli","credential":"MD","specialty":"Hematology / Oncology","specialty_raw":"Hematology & Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"city":"Arlington","state":"TX","region":{"label":"South Central","url":"https://www.findmykol.com/region/south-central"}},"identifiers":{"npi":"1497921829","openalex":"A5038267628"},"summary":"Revathi Angitapalli is an Oncology physician. OpenAlex indexes 7 publications with 220 citations (h-index 3).","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":7,"cited_by_count":220,"h_index":3,"latest_activity_year":2025,"source":"works"},"payments":{"company_count":72,"program_years":{"first":2021,"last":null},"rows_total":149,"shown":3,"withheld":146,"rows":[{"payer":"Novartis Pharmaceuticals Corporation","program_year":2025,"amount_usd":1253.34,"payment_count":19,"source_url":"https://openpaymentsdata.cms.gov/search?query=1497921829"},{"payer":"Celgene Corporation","program_year":2025,"amount_usd":316.28,"payment_count":11,"source_url":"https://openpaymentsdata.cms.gov/search?query=1497921829"},{"payer":"Merck Sharp & Dohme LLC","program_year":2025,"amount_usd":249.71,"payment_count":9,"source_url":"https://openpaymentsdata.cms.gov/search?query=1497921829"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1497921829","source":"payments"},"prescribing":{"data_year":2024,"areas_total":9,"areas_shown":3,"areas":[{"area":"Blood & clotting","share_pct":64.1,"classes_total":3,"classes":[{"class":"Iron, parenteral preparations","setting":"administered","share_pct":63.9,"drugs":[{"name":"Ferric carboxymaltose","share_pct":100}],"max_beneficiaries":23},{"class":"Factor Xa inhibitor","setting":"prescribed","share_pct":0.2,"drugs":[{"name":"Eliquis","share_pct":77},{"name":"Xarelto","share_pct":23}],"max_beneficiaries":null}]},{"area":"Metabolism & gastrointestinal","share_pct":26.5,"classes_total":4,"classes":[{"class":"Other antiemetics","setting":"administered","share_pct":24.4,"drugs":[{"name":"Fosaprepitant","share_pct":100}],"max_beneficiaries":18},{"class":"Serotonin-3 Receptor Antagonist","setting":"mixed","share_pct":2,"drugs":[{"name":"Palonosetron hcl","share_pct":98.7},{"name":"Ondansetron Odt","share_pct":1.3}],"max_beneficiaries":null}]},{"area":"Musculoskeletal","share_pct":4.5,"classes_total":2,"classes":[{"class":"RANK Ligand Inhibitor","setting":"administered","share_pct":4,"drugs":[{"name":"Denosumab","share_pct":100}],"max_beneficiaries":14},{"class":"Bisphosphonate","setting":"administered","share_pct":0.5,"drugs":[{"name":"Zoledronic acid","share_pct":100}],"max_beneficiaries":28}]}],"care_setting":{"dominant":"office","data_year":2024,"office_pct":100,"facility_pct":0},"source":"medicare"},"publications":{"total":7,"shown":5,"withheld":2,"matched_by":"OpenAlex author record","recent":[{"title":"The Journal of Experimental Medicine CORRESPONDENCE","year":2013,"status":"verified"},{"title":"Adjuvant FOLFOX Chemotherapy and Splenomegaly in Patients with Stages II–III Colorectal Cancer","year":2009,"journal":"Oncology","source_url":"https://doi.org/10.1159/000210025","status":"verified"},{"title":"Increase in splenic volume suggesting unrecognized portal hypertension resulting from adjuvant FOLFOX chemotherapy in colorectal cancer (CRC)","year":2008,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2008.26.15_suppl.15028","status":"verified"},{"title":"Lymphocyte Depletion in Breast Cancer Patients Receiving Adjuvant Dose-Dense Chemotherapy.","year":2007,"journal":"Blood","source_url":"https://doi.org/10.1182/blood.v110.11.3873.3873","status":"verified"},{"title":"Enhancement of clonogenicity of human multiple myeloma by dendritic cells","year":2006,"journal":"The Journal of Experimental Medicine","source_url":"https://doi.org/10.1084/jem.20052136","status":"verified"}],"source":"works"},"contact":{"address_1":"515 W MAYFIELD RD STE 102","city":"Arlington","state":"TX","zip":"760142084","phone":"817-759-7000","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1497921829","source":"identity"},"similar":[{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Beth Karlan","slug":"beth-karlan","institution":"University of California, Los Angeles","specialty":"Gynecologic Oncology","url":"https://www.findmykol.com/kol/beth-karlan","json_url":"https://www.findmykol.com/kol/beth-karlan/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":146,"publications":2}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2025-02-06","provider_certified":"2025-02-06","collected_at":"2026-11-06T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024}},"methodology_url":"https://www.findmykol.com/about#methodology"}